These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

782 related articles for article (PubMed ID: 22640807)

  • 21. Targeting the Th17 pathway in psoriasis.
    Elloso MM; Gomez-Angelats M; Fourie AM
    J Leukoc Biol; 2012 Dec; 92(6):1187-97. PubMed ID: 22962689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis.
    Jadidi-Niaragh F; Mirshafiey A
    Scand J Immunol; 2011 Jul; 74(1):1-13. PubMed ID: 21338381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases.
    Yamagata T; Skepner J; Yang J
    Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):405-14. PubMed ID: 26358867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tacrolimus potently inhibits human osteoclastogenesis induced by IL-17 from human monocytes alone and suppresses human Th17 differentiation.
    Yago T; Nanke Y; Kawamoto M; Yamanaka H; Kotake S
    Cytokine; 2012 Aug; 59(2):252-7. PubMed ID: 22579702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F.
    Leppkes M; Becker C; Ivanov II; Hirth S; Wirtz S; Neufert C; Pouly S; Murphy AJ; Valenzuela DM; Yancopoulos GD; Becher B; Littman DR; Neurath MF
    Gastroenterology; 2009 Jan; 136(1):257-67. PubMed ID: 18992745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?
    Lubberts E
    Cytokine; 2008 Feb; 41(2):84-91. PubMed ID: 18039580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
    Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
    Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Generation of engineering Th17 cells and its function evaluation].
    Zhang HX; Chen C; Zeng LY; Zhang Y; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):825-9. PubMed ID: 22339955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation.
    Annunziato F; Cosmi L; Liotta F; Maggi E; Romagnani S
    Int Immunol; 2008 Nov; 20(11):1361-8. PubMed ID: 18820263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular underpinnings of Th17 immune-regulation and their implications in autoimmune diabetes.
    Kumar P; Subramaniyam G
    Cytokine; 2015 Feb; 71(2):366-76. PubMed ID: 25510901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
    Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
    Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The potential role of Th17 in mediating the transition from acute to chronic autoimmune inflammation: rheumatoid arthritis as a model.
    Ferraccioli G; Zizzo G
    Discov Med; 2011 May; 11(60):413-24. PubMed ID: 21616040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New insights into the pathogenesis of cutaneous autoimmune disorders.
    Chiricozzi A; Zhang S; Dattola A; Cannizzaro MV; Gabellini M; Chimenti S; Nistico SP
    J Biol Regul Homeost Agents; 2012; 26(2):165-70. PubMed ID: 22824743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IFN-beta inhibits human Th17 cell differentiation.
    Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
    J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-17: a new actor in IFN-driven systemic autoimmune diseases.
    Ambrosi A; Espinosa A; Wahren-Herlenius M
    Eur J Immunol; 2012 Sep; 42(9):2274-84. PubMed ID: 22949326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
    Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
    Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High dose lipopolysaccharide triggers polarization of mouse thymic Th17 cells in vitro in the presence of mature dendritic cells.
    Wang L; Xiao W; Zheng Y; Xiao R; Zhu G; Wang M; Li Y; Peng S; Tan X; He Y; Tan J
    Cell Immunol; 2012; 274(1-2):98-108. PubMed ID: 22361175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis.
    Hirota K; Hashimoto M; Yoshitomi H; Tanaka S; Nomura T; Yamaguchi T; Iwakura Y; Sakaguchi N; Sakaguchi S
    J Exp Med; 2007 Jan; 204(1):41-7. PubMed ID: 17227914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-17 in systemic lupus erythematosus: A comprehensive review.
    Li D; Guo B; Wu H; Tan L; Chang C; Lu Q
    Autoimmunity; 2015; 48(6):353-61. PubMed ID: 25894789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.